← Browse by Condition
Medical Condition

resectable stage ib iii non squamous non small cell lung cancer

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 2
NCT07122687 Phase 2
Recruiting

IBI363 Combined With Chemotherapy or Pembrolizumab Combined With Chemotherapy as Neoadjuvant Therapy in Resectable Stage IB-III Non-Squamous Non-Small Cell Lung Cancer

Enrollment
170 pts
Location
China
Sponsor
Innovent Biologics (Suzhou) Co...
View Trial →